VANCOUVER, BRITISH COLUMBIA, Sep. 9, 2010 (Marketwire) -- EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) today announced the appointment of Philip M. Fitzpatrick as Executive Business Development Advisor. Mr. Fitzpatrick has previously held senior positions with a number of multi-national food and protein companies including Unilever, the Dole Food Company, and Marine Harvest, where he assisted in the development of best-in-class business development and sales divisions that resulted in over $100 million in new value-added products. Mr. Fitzpatrick will use his extensive experience in the global food industry to further expand the market for EnWave's nutraREV(TM) food dehydration technology.
"With the addition of Phil as an advisor, we have further strengthened our management team and are now in a better position to expedite current negotiations and identify additional multi-national partners moving forward," said Dr. Tim Durance, Chairman & Co-CEO of EnWave. "Phil is well respected by the food industry, and I anticipate that his broad experience in company start-up, business development, product launch, customer targeting and negotiation will add to the significant momentum that we have already achieved at EnWave."
Based in Florida, U.S.A., Mr. Fitzpatrick will assist the Company to establish multi-national partnerships in the food sector with the goal of establishing a global nutraDried(TM) brand for tasty, healthy fruit and vegetable snack products.
Using proprietary technologies developed in conjunction with the University of British Columbia, EnWave is commercializing a new method for dehydrating food and biological materials using Radiant Energy Vacuum technology under its nutraREV(TM), powderREV(TM), bioREV(TM) and freezeREV(TM) brands. REV technology combines microwave energy transfer under vacuum to dehydrate and alter structures and drive chemical reactions, thereby creating unique product characteristics for both food products and medical applications that include fruit, vegetables, probiotics, enzymes, proteins, food cultures, vaccines and antibodies. More information about EnWave is available at www.enwave.net.
Dr. Tim Durance, Chairman & Co-CEO
Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. There is no guarantee that the Company's REV technology can or will improve processes in the target industry; even if the Company's REV technology can be used as described in this document, there is no guarantee that such use will result in orders for the Company's REV technology. All figures comparing REV technologies to freeze drying or other dehydration technologies are provided as examples of data obtained through the Company's own scientific and testing programs; each product must be tested individually to determine the benefits of using REV.
The TSX Venture Exchange has neither approved nor disapproved the information contained herein. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Mr. John McNicol
President & Co-CEO
V.P. Corporate Development & Investor Relations